Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.00 (0.00%)
Bid:
94.00
Ask:
100.00
Spread: 6.00 (6.383%)
Market Cap: £105.90m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Full Year Trading Update

29 Jan 2021 07:00

RNS Number : 2838N
Inspecs Group PLC
29 January 2021
 

29 January 2021

 

Inspecs Group plc

("Inspecs", the "Company" or "the Group")

 

Full Year Trading Update

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, today announces a trading update for the year ended 31 December 2020 ahead of its Final Results in May 2021.

 

The Group's trading performance for the year was in line with management's expectations, delivering Group revenue of $46.2m (2019: $61.2m). The Group completed two acquisitions in the year, namely the assets of The Norville Group Ltd ("Norville") on 14 July 2020 and Eschenbach Optik GmbH ("Eschenbach Optik") on 16 December 2020. These businesses contributed revenue of $4.2m and $3.1m respectively. Integration of Norville is complete and the integration of Eschenbach Optik is progressing to plan, showing encouraging early signs. We now look forward to working with the Eschenbach Optik team to drive the identified synergies and boost Inspecs' global footprint and brand portfolio.

 

Robin Totterman, CEO of Inspecs, said:

 

"Whilst 2020 was an extraordinary year for a number of reasons, it was a milestone year for Inspecs with the Company successfully listing on AIM in February and subsequently completing two acquisitions. Welcoming Norville and Eschenbach Optik to the Group significantly increases our global distribution and lens manufacturing capability, enabling us to penetrate key global markets, broaden our customer reach, and strengthen our brand portfolio.

 

"Although the global pandemic continues, the Group is in a strong position to capitalise on the compelling structural opportunities that exist in the fragmented global eyewear market. I would like to thank all of our employees across the globe for their continued hard work and resilience in the face of the ever-changing pandemic and I continue to look to the future with confidence."

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Will Bell

Tel: +44 (0) 20 7418 8900

 

FTI Consulting (Financial PR)

Alex Beagley

James Styles

Fern Duncan

Alice Newlyn

Tel: +44 (0) 20 3727 1000

 

 

About Inspecs Group plc

 

Inspecs is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

 

In December 2020, Inspecs acquired Eschenbach Optik, a leading, global, eyewear supplier headquartered in Nürnberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby Inspecs combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market.

 

Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 40,000 points of sale. In FY19, the Group generated 24.9% of its revenue in the UK and 75.1% internationally.

 

Today Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, London and more recently, Italy. With the acquisition of Eschenbach Optik, the Group's international reach further extends to Germany, France, Spain, Japan and Poland.

 

The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

More information is available at: https://inspecs.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWSWRAKUAUAR
Date   Source Headline
30th Oct 202510:29 amBUSForm 8.3 - Inspecs Group plc
30th Oct 202510:06 amGNWForm 8.5 (EPT/RI)-Inspecs Group PLC
30th Oct 20258:55 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20256:15 pmRNSForm 8.3 - Inspecs Group Plc
29th Oct 20254:13 pmRNSForm 8.3 - Inspecs Group PLC
29th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group Plc
29th Oct 202510:00 amGNWForm 8.5 (EPT/RI)-Inspecs Group PLC
29th Oct 20259:50 amGNWForm 8.3 - Inspecs Group Plc
29th Oct 20258:25 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20257:00 amRNSStatement re First Seagull letter
28th Oct 20254:35 pmRNSForm 8 (OPD) - Inspecs Group Plc
28th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group Plc
28th Oct 20259:49 amRNSForm 8.3 - Inspecs Group Plc
28th Oct 20258:55 amRNSForm 8.5 (EPT/NON-RI)
27th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group Plc
27th Oct 202510:53 amGNWForm 8.5 (EPT/RI)- Amendment of Inspecs Group PLC
27th Oct 202510:00 amGNWForm 8.5 (EPT/RI)-Inspecs Group PLC
27th Oct 20259:26 amRNSForm 8.5 (EPT/NON-RI)
24th Oct 20251:22 pmRNSForm 8.3 - Inspecs Group PLC
24th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group Plc
24th Oct 202510:41 amGNWForm 8.3 - Inspecs Group Plc
24th Oct 20259:58 amBUSForm 8.3 - Inspecs Group plc
24th Oct 20259:50 amGNWForm 8.3 - [INSPECS GROUP PLC - Opening Disclosure - 23 10 2025] - (CGAML)
24th Oct 20259:10 amRNSForm 8.5 (EPT/NON-RI)
24th Oct 20258:20 amGNWForm 8.5 (EPT/RI)-Inspecs Group PLC
23rd Oct 20256:17 pmRNSForm 8.3 - Inspecs Group Plc
23rd Oct 20254:32 pmRNSStatement re Possible Offer
18th Sep 20257:00 amRNSInterim Results
18th Sep 20257:00 amRNSAppointment of Non-Executive Chair
31st Jul 20257:00 amRNSHalf Year Trading Update
4th Jun 202511:10 amRNSDirector/PDMR Share Dealing
3rd Jun 20254:29 pmRNSResult of AGM
3rd Jun 20257:00 amRNSAGM Statement
29th May 20257:00 amRNSBoard composition and General Meeting update
23rd May 20257:00 amRNSHolding(s) in Company
14th May 20257:00 amRNSResponse to requisition of a General Meeting
8th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
16th Apr 202510:30 amRNSBoard update
15th Apr 20257:00 amRNSUpdate on full year results
10th Apr 20257:00 amRNSCFO Succession
10th Apr 20257:00 amRNSFinal Results
5th Mar 20257:00 amRNSHolding(s) in Company
5th Feb 20257:00 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSTrading Update
20th Dec 20247:00 amRNSBoard Composition
16th Dec 20247:00 amRNSBanking Facilities – Renewal to 2027
9th Dec 20247:00 amRNSTrading Update
23rd Oct 20243:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.